Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-3-19
pubmed:abstractText
Human cancer is characterized by complex molecular perturbations leading to variable clinical behavior, often even in single-disease entities. We performed a feasibility study systematically comparing large-scale gene expression profiles with clinical features in human B-cell chronic lymphocytic leukemia (B-CLL). cDNA microarrays were employed to determine the expression levels of 1,024 selected genes in 54 peripheral blood lymphocyte samples obtained from patients with B-CLL. Statistical analyses were applied to correlate the expression profiles with a number of clinical parameters including patient survival and disease staging. We were able to identify genes whose expression levels significantly correlated with patient survival and/or with clinical staging. Most of these genes code either for cell adhesion molecules (L-selectin, integrin-beta2) or for factors inducing cell adhesion molecules (IL-1beta, IL-8, EGR1), suggesting that prognosis of this disease may be related to a defect in lymphocyte trafficking. This report demonstrates the feasibility of a systematic integration of large-scale gene expression profiles with clinical data as a general approach for dissecting human diseases.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0020-7136
pubmed:author
pubmed:copyrightInfo
Copyright 2001 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
91
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
474-80
pubmed:dateRevised
2007-7-24
pubmed:meshHeading
pubmed-meshheading:11251968-Adult, pubmed-meshheading:11251968-Aged, pubmed-meshheading:11251968-Aged, 80 and over, pubmed-meshheading:11251968-Antigens, CD18, pubmed-meshheading:11251968-Cell Adhesion, pubmed-meshheading:11251968-DNA, Complementary, pubmed-meshheading:11251968-DNA-Binding Proteins, pubmed-meshheading:11251968-Early Growth Response Protein 1, pubmed-meshheading:11251968-Feasibility Studies, pubmed-meshheading:11251968-Female, pubmed-meshheading:11251968-Flow Cytometry, pubmed-meshheading:11251968-Humans, pubmed-meshheading:11251968-Immediate-Early Proteins, pubmed-meshheading:11251968-Immunohistochemistry, pubmed-meshheading:11251968-Immunophenotyping, pubmed-meshheading:11251968-Interleukin-1, pubmed-meshheading:11251968-Interleukin-8, pubmed-meshheading:11251968-L-Selectin, pubmed-meshheading:11251968-Leukemia, B-Cell, pubmed-meshheading:11251968-Lymphocytes, pubmed-meshheading:11251968-Male, pubmed-meshheading:11251968-Middle Aged, pubmed-meshheading:11251968-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:11251968-Plasmids, pubmed-meshheading:11251968-Prognosis, pubmed-meshheading:11251968-RNA, pubmed-meshheading:11251968-Time Factors, pubmed-meshheading:11251968-Transcription Factors
pubmed:year
2001
pubmed:articleTitle
CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking.
pubmed:affiliation
Boehringer Ingelheim Austria, Exploratory Research, Dr. Boehringergasse 5-11, A-1121 Vienna, Austria. christian.stratowa@vie.boehringer-ingelheim.com
pubmed:publicationType
Journal Article